Veracyte, Inc. - Common Stock (NQ:VCYT)

45.74 -0.07 (-0.15%)

Delayed Quote Updated: 10:08 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Veracyte, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Veracyte Announces Key Appointments to Executive Leadership Team, Supporting Global Expansion

July 08, 2021

From Veracyte, Inc.

Via Business Wire

Mid-Cap Biotech Picks: Seasonal Rally Underway ↗

July 03, 2021

Many Mid-Cap biotech stocks were hit hard after the February peak. We suggest three new mid-cap biotech picks. All three picks can be volatile but very tradable.

Via Talk Markets

Veracyte Announces Two Pre-Eminent Physician Appointments, Further Strengthening Medical Team

July 01, 2021

From Veracyte, Inc.

Via Business Wire

Expert Ratings For Veracyte ↗

June 28, 2021

Within the last quarter, Veracyte (NASDAQ:VCYT) has observ...

Via Benzinga

Expert Ratings for Veracyte ↗

May 11, 2021

Analysts have provided the following ratings for Veracyte (NASDAQ:VCYT) within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 1 0 0 0...

Via Benzinga

Earnings Scheduled For May 10, 2021 ↗

May 10, 2021

Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report...

Via Benzinga

Looking Into Veracyte's Return On Capital Employed ↗

June 25, 2021

During Q1, Veracyte's (NASDAQ:VCYT) reported sales totaled $36.70 million. Despite a 462.62% in earnings, the company posted a loss of $45.41 million. Veracyte collected $34.54...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021 ↗

June 15, 2021

Upgrades According to Raymond James, the prior rating for Welltower Inc (NYSE:WELL) was changed from Market Perform to Strong Buy. For the first quarter, Welltower had an...

Via Benzinga

New Data Published in JAMA Oncology Demonstrate Prognostic Utility of Veracyte’s Decipher Prostate Genomic Classifier in Locally Advanced Prostate Cancer

June 14, 2021

From Veracyte, Inc.

Via Business Wire

Veracyte: Return On Capital Employed Insights ↗

June 09, 2021

In Q1, Veracyte (NASDAQ:VCYT) posted sales of $36.70 million. Earnings were up 462.62%, but Veracyte still reported an overall loss of $45.41 million. Veracyte collected $34.54...

Via Benzinga

Veracyte Receives Final Medicare Coverage Policies for Decipher Bladder

June 04, 2021

From Veracyte, Inc.

Via Business Wire

CORRECTING and REPLACING Veracyte to Present at Upcoming Investor Conferences

June 02, 2021

From Veracyte, Inc.

Via Business Wire

Veracyte to Present at Upcoming Investor Conferences

June 02, 2021

From Veracyte, Inc.

Via Business Wire

Veracyte Strengthens Cancer Diagnostics Portfolio with HalioDx Acquisition ↗

June 01, 2021

Veracyte Inc (NASDAQ: VCYT) has agreed to acquire HalioDx in a €260 million transaction to accelerate growth and strengthen its position in cancer diagnostics...

Via Benzinga

Veracyte to Acquire HalioDx, Positioning for Global Cancer Diagnostics Growth

June 01, 2021

From Veracyte, Inc.

Via Business Wire

Veracyte to Present at Upcoming Investor Conferences

May 26, 2021

From Veracyte

Via Business Wire

Veracyte Announces New Data Demonstrating Afirma Xpression Atlas Identifies Clinically Relevant Gene Fusions in Thyroid Cancer FNA Samples

May 26, 2021

From Veracyte, Inc.

Via Business Wire

Veracyte Announces New Data at ASCO 2021 Reinforcing Prognostic Utility of Decipher Prostate Genomic Classifier

May 25, 2021

From Veracyte, Inc.

Via Business Wire

Veracyte Announces New Pivotal Clinical Validation Data at ASCO Showing Noninvasive Nasal Swab Test Can Significantly Improve Early Lung Cancer Detection

May 19, 2021

From Veracyte, Inc.

Via Business Wire

Veracyte to Present at Upcoming Investor Conferences

May 18, 2021

From Veracyte, Inc.

Via Business Wire

Veracyte Announces Data Reinforcing the Diagnostic Performance and Utility of the Envisia Genomic Classifier in ILD Diagnosis

May 14, 2021

From Veracyte

Via Business Wire

Veracyte Announces Data Showing Percepta Genomic Atlas Detects Gene Alterations Targeted in Lung Cancer Treatment, Using Diagnostic Biopsy

May 14, 2021

From Veracyte, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 12, 2021

Gainers Celyad Oncology (NASDAQ:CYAD) sto...

Via Benzinga

Veracyte, Inc. Announces CEO Succession Plan

May 10, 2021

From Veracyte, Inc.

Via Business Wire

Cathie Wood Loads Up $57M In Palantir As Stock Stages Reversal On Q1 Earnings Beat ↗

May 12, 2021

Cathie Wood-led Ark Investment Management on Tuesday snapped up 2.8 million shares, worth about $56.7 million, in Palantir Technologies Inc (NYSE: PLTR) after the data analytics...

Via Benzinga

Veracyte Announces First Quarter 2021 Financial Results

May 10, 2021

From Veracyte, Inc.

Via Business Wire

Cathie Wood Cuts Apple Stake By 30% And Buys Coinbase, DraftKings ↗

May 10, 2021

Cathie Wood-led Ark Investment Management shed more shares of Apple Inc (NASDAQ:

Via Benzinga

Cathie Wood Loads Up Another $28M Worth Of Shares In Alibaba Rival JD.Com ↗

May 09, 2021

Cathie Wood-led Ark Investment Management on Friday bought 366,879 shares, worth about $27.7 million, in JD.com Inc (NASDAQ: JD), a key rival to Alibaba Group Holding (NYSE: BABA...

Via Benzinga

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗

May 09, 2021

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...

Via Benzinga

Cathie Wood Slashes Apple Stake To Half — Also Trims Google, Fastly: What You Need To Know ↗

May 07, 2021

Cathie Wood-led Ark Investment Management nearly halved the Apple Inc (NASDAQ: AAPL) stake in the ARK Fintech Innovation ETF (NYSE: ARKF) on Thursday. ARKF shed 298,505 Apple...

Via Benzinga

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.